Update shared on17 Sep 2025
Fair value Decreased 2.61%The slight reduction in Tate & Lyle’s consensus price target reflects a modest decline in net profit margin, resulting in a new fair value of £7.09.
What's in the News
- Tate & Lyle is showcasing health-focused ingredient innovations at the IFT FIRST Conference, including advancements in sugar reduction, fiber fortification, and novel textures.
- The company is introducing four new prototypes such as a dual-textured Pina Colada gummy lollipop, highlighting the capabilities of GENU® Pectin and GENUTINE® Carrageenan.
- Interactive demos at the Mouthfeel Lab illustrate how Tate & Lyle's stabilizer and hydrocolloid solutions enhance mouthfeel, texture, and product experience.
- Scientific presentations will spotlight the U.S.-sourced, bio-converted All-Americas Stevia Reb M sweetener, and advances in optimizing mouthfeel for crackers.
- Tate & Lyle is progressing on sustainability goals, with new SBTi-approved emissions reduction targets, lower carbon and water use in select products, and award recognition for its sustainable stevia program.
Valuation Changes
Summary of Valuation Changes for Tate & Lyle
- The Consensus Analyst Price Target has fallen slightly from £7.28 to £7.09.
- The Net Profit Margin for Tate & Lyle has fallen slightly from 11.02% to 10.80%.
- The Future P/E for Tate & Lyle remained effectively unchanged, moving only marginally from 18.83x to 18.72x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.